Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
30 September 2021 | Story Ruan Bruwer | Photo Varsity Sports
Thabo Lesibe, captain of the UFS team, on his way to score the winning goal against Tuks in the semi-final of Varsity Football.


To finish his very last match for the Kovsies as the winning captain of Varsity Football would mean the world to him, says Thabo Lesibe.

The University of the Free State (UFS) men’s team reached the final of Varsity Football for the very first time. They will face the University of Johannesburg (UJ) in Pretoria on Monday, 4 October 2021. The match gets underway at 19:15.

The UFS booked their spot in the final thanks to a 2-1 victory over Tuks in Tuesday’s semi-final.

“It would certainly be the cherry on the cake and the best possible way for me to bow out,” Lesibe said. He is in his final year of study for a Bachelor of Laws, which he started in 2015. Lesibe was responsible for scoring the winning goal from a penalty against Tuks. 

On their way to the semi-finals, Kovsies also defeated the University of KwaZulu-Natal, Tuks, and Wits and drew against the North-West University (NWU), Tshwane University of Technology, and the Vaal University of Technology. Their only loss was against UJ (0-1).

“It feels amazing to reach the final. We are all very excited. There is a strong unity in the camp and a common belief. We are playing for something far greater than the eye can see,” the captain said.

According to Lesibe, the pain of 2019 has been a motivator for them in 2021. In the 2019 Varsity Football competition, Kovsies and NWU finished level on log points and with the same goal difference, but NWU progressed to the semis courtesy of scoring nine goals to the UFS’s eight in the group stage.

“When it gets tough on the playing field, we remind ourselves of that disappointment which propelled us, as we did not want to experience that pain again.”

Prof Francis Petersen, Rector and Vice-Chancellor of the UFS, congratulated the team on a successful Varsity Football season. 
“This is a great achievement for the team as well as for the university. You have shown once again that the University of the Free State is home to top sports stars. Following the victory of our Kovsie Netball team, we look forward to adding another title to our sporting achievements this year.”

News Archive

UFS to monitor the use of ARV-drugs on pregnant women and children
2004-12-08

The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.

The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.

The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.

“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.

“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.

According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.

The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.

According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.

The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.

Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept